Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XLCART001 in Relapsed/Refractory/High-risk B-cell Malignancy
NCT03598179Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of XLCART001 in B cell lymphoma, acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
XLCART001
03
Conditions
B cell lymphomaacute lymphoblastic leukemia (ALL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT03598179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598179.